Výsledky vyhľadávania - "HIV Envelope Protein gp41/therapeutic use"

Baseline Susceptibility of Primary HIV-2 to Entry Inhibitors

Autori: Borrego, Pedro Calado, Rita Marcelino, José M. a ďalší

Prispievatelia: Borrego, Pedro Calado, Rita Marcelino, José M. a ďalší

Zdroj: Antiviral Therapy. 17:565-570

Predmety: Male, 0301 basic medicine, Cyclohexanes/pharmacology, Amides/therapeutic use, Anti-HIV Agents, HIV Fusion Inhibitors/pharmacology, HCC INF, HIV Infections/drug therapy, HIV Infections, Microbial Sensitivity Tests, Cyclohexanes/therapeutic use, Enfuvirtide, HIV Envelope Protein gp41/therapeutic use, Maraviroc, Inhibitory Concentration 50, 03 medical and health sciences, Cyclohexanes, HIV Fusion Inhibitors, HSJ MED, Anti-HIV Agents/pharmacology, inhibitors, Humans, Amides/pharmacology, Peptide Fragments/therapeutic use, Quaternary Ammonium Compounds/therapeutic use, 0303 health sciences, Peptide Fragments/pharmacology, Triazoles/pharmacology, Quaternary Ammonium Compounds/pharmacology, HIV Fusion Inhibitors/therapeutic use, HIV Envelope Protein gp41/pharmacology, Triazoles, Amides, HIV Envelope Protein gp41, Peptide Fragments, 3. Good health, HIV-2/drug effects, Quaternary Ammonium Compounds, HIV-1/drug effects, Anti-HIV Agents/therapeutic use, CCR5 Receptor Antagonists, HIV-2, HIV-1, HIV Infections/virology, Female, Triazoles/therapeutic use

Popis súboru: application/pdf

Prístupová URL adresa: http://repositorio.chlc.min-saude.pt/bitstream/10400.17/2417/1/Antiviral%20Therapy%202011.pdf
https://pubmed.ncbi.nlm.nih.gov/22293827
https://www.ncbi.nlm.nih.gov/pubmed/22293827
https://europepmc.org/abstract/MED/22293827
http://comum.rcaap.pt/bitstream/10400.26/4993/1/Borrego%20et%20al%20%20Antiviral%20Therapy%202011.pdf
http://www.intmedpress.com/journals/avt/abstract.cfm?id=1996&pid=48
https://repositorio.chlc.min-saude.pt/bitstream/10400.17/2417/1/Antiviral%20Therapy%202011.pdf
https://pubmed.ncbi.nlm.nih.gov/22293827/
https://hdl.handle.net/10400.26/4993
https://hdl.handle.net/10451/59111
http://hdl.handle.net/10400.17/2417

Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection

Autori: Fätkenheuer, Gerd Nelson, Mark Lazzarin, Adriano a ďalší

Prispievatelia: Fätkenheuer, Gerd Nelson, Mark Lazzarin, Adriano a ďalší

Zdroj: New England Journal of Medicine, Vol. 359, No 14 (2008) pp. 1442-1455

Predmety: Male, 0301 basic medicine, HIV Infections, Enfuvirtide, Immunologie & maladie infectieuse, HIV Envelope Protein gp41/therapeutic use, 0302 clinical medicine, Transaminases/blood, HIV Fusion Inhibitors, Odds Ratio, Ethnicity, Immunology & infectious disease, Human health sciences, ddc:616, HIV Infections/drug therapy/immunology/virology, Receptors, CCR5/antagonists & inhibitors/genetics, Middle Aged, Viral Load, Hepatitis B, Hepatitis C, HIV-1/chemistry/genetics, HIV Envelope Protein gp41, 3. Good health, Treatment Outcome, Anti-Retroviral Agents, HIV Fusion Inhibitors/adverse effects/therapeutic use, CCR5 Receptor Antagonists, Drug Therapy, Combination, Female, Cyclohexanes/adverse effects/therapeutic use, Adult, Genotype, Triazoles/adverse effects/therapeutic use, Ethnic Groups, Sciences de la santé humaine, 03 medical and health sciences, EMC MM-04-28-04, SDG 3 - Good Health and Well-being, Double-Blind Method, Cyclohexanes, Humans, RNA, Viral/blood, Aged, Hepatitis B/blood/complications, Peptide Fragments/therapeutic use, Anti-Retroviral Agents/adverse effects/therapeutic use, CD4 Lymphocyte Count, HIV-1, Hepatitis C/blood/complications

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/18832245
https://pure.eur.nl/en/publications/02d81c5a-0d7c-4757-80b6-550ce7f47f74
https://archive-ouverte.unige.ch/unige:2103
https://orbi.uliege.be/handle/2268/16294
https://www.ncbi.nlm.nih.gov/pubmed/18832245
https://moh-it.pure.elsevier.com/en/publications/subgroup-analyses-of-maraviroc-in-previously-treated-r5-hiv-1-inf
https://europepmc.org/abstract/MED/18832245
https://www.nejm.org/doi/abs/10.1056/NEJMoa0803154
https://archive-ouverte.unige.ch/unige:2103
https://archive-ouverte.unige.ch/unige:2103
https://doi.org/10.1056/nejmoa0803154
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000259631700005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=0c7ff228ccbaaa74236f48834a34396a
https://doi.org/10.1056/NEJMoa0803154
https://hdl.handle.net/11573/84304